{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:30:09Z","timestamp":1787679009104,"version":"build-2784847793"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Neurobiology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.conb.2021.09.004","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T02:08:42Z","timestamp":1633745322000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Rodent models based on endolysosomal genes involved in Parkinson's disease"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1773-8696","authenticated-orcid":false,"given":"Mar\u00eda","family":"Sanchiz-Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Bentea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Baekelandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conb.2021.09.004_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","article-title":"The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.conb.2021.09.004_bib2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.conb.2021.09.004_bib3","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A\u00a0meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.conb.2021.09.004_bib4","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.09.004_sref5","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1111\/febs.14936","article-title":"DNAJC proteins and pathways to parkinsonism","volume":"286","author":"Roosen","year":"2019","journal-title":"FEBS J"},{"key":"10.1016\/j.conb.2021.09.004_bib6","article-title":"Mutations in Auxilin cause parkinsonism via impaired clathrin-mediated trafficking at the Golgi apparatus and synapse","author":"Roosen","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.conb.2021.09.004_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/bs.pbr.2020.02.001","article-title":"Endosomal sorting pathways in the pathogenesis of Parkinson's disease","volume":"252","author":"Cunningham","year":"2020","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.conb.2021.09.004_bib8","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.neuron.2017.01.019","article-title":"Parkinson sac domain mutation in synaptojanin 1 impairs clathrin uncoating at synapses and triggers dystrophic changes in dopaminergic axons","volume":"93","author":"Cao","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2021.09.004_sref9","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1093\/hmg\/ddaa080","article-title":"Synj1 haploinsufficiency causes dopamine neuron vulnerability and alpha-synuclein accumulation in mice","volume":"29","author":"Pan","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.09.004_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10571-020-00849-8","article-title":"The role of VPS35 in the pathobiology of Parkinson's disease","volume":"41","author":"Sassone","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.conb.2021.09.004_bib11","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1093\/hmg\/ddu178","article-title":"Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration","volume":"23","author":"Tsika","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.09.004_sref12","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1073\/pnas.1814909116","article-title":"Parkinson's disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration","volume":"116","author":"Chen","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.conb.2021.09.004_sref13","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13347","article-title":"VPS35 D620N knockin mice recapitulate cardinal features of Parkinson's disease","author":"Niu","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.conb.2021.09.004_bib14","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.celrep.2015.08.001","article-title":"VPS35 deficiency or mutation causes dopaminergic neuronal loss by impairing mitochondrial fusion and function","volume":"12","author":"Tang","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.conb.2021.09.004_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuron.2014.11.027","article-title":"Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on alpha-synuclein","volume":"85","author":"Dhungel","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2021.09.004_bib16","first-page":"1271","article-title":"LRRK2 and the endolysosomal system in Parkinson's disease","volume":"10","author":"Erb","year":"2020","journal-title":"J\u00a0Parkinsons Dis"},{"key":"10.1016\/j.conb.2021.09.004_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ceb.2020.01.001","article-title":"Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease","volume":"63","author":"Taylor","year":"2020","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.conb.2021.09.004_bib18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3389\/fnins.2020.00674","article-title":"Progress in LRRK2-associated Parkinson's disease animal models","volume":"14","author":"Seegobin","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.conb.2021.09.004_bib19","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1073\/pnas.1712648115","article-title":"Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice","volume":"115","author":"Xiong","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.conb.2021.09.004_bib20","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.2199","article-title":"Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease","volume":"16","author":"Lee","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.conb.2021.09.004_bib21","doi-asserted-by":"crossref","first-page":"17296","DOI":"10.1073\/pnas.1922184117","article-title":"Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity","volume":"117","author":"Nguyen","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.conb.2021.09.004_sref22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/hmg\/ddz271","article-title":"G2019S-LRRK2 mutation enhances MPTP-linked Parkinsonism in mice","volume":"29","author":"Arbez","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.09.004_bib23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/brain\/awx344","article-title":"Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers","volume":"141","author":"Zhao","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.09.004_bib24","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1042\/BCJ20180248","article-title":"The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human","volume":"475","author":"Mir","year":"2018","journal-title":"Biochem J"},{"key":"10.1016\/j.conb.2021.09.004_bib25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fnins.2020.00719","article-title":"LRRK2 and protein aggregation in Parkinson's disease: insights from animal models","volume":"14","author":"Dues","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.conb.2021.09.004_sref26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s13311-021-01007-8","article-title":"LRRK2 ablation Attenuates alphalpha-synuclein-induced neuroinflammation without affecting neurodegeneration or neuropathology in\u00a0vivo","volume":"18","author":"Van der Perren","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.conb.2021.09.004_bib27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fnins.2020.00376","article-title":"Multiple-hit hypothesis in Parkinson's disease: LRRK2 and inflammation","volume":"14","author":"Cabezudo","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.conb.2021.09.004_bib28","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/brain\/awy077","article-title":"Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in\u00a0vivo","volume":"141","author":"Kozina","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.09.004_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/10409239009090616","article-title":"Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease","volume":"25","author":"Grabowski","year":"1990","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.conb.2021.09.004_bib30","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.conb.2021.09.004_bib31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tins.2019.05.010","article-title":"Can GBA1-associated Parkinson disease Be modeled in the mouse?","volume":"42","author":"Farfel-Becker","year":"2019","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.conb.2021.09.004_bib32","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/brain\/awx221","article-title":"The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice","volume":"140","author":"Migdalska-Richards","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.09.004_sref33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238075","article-title":"L444P Gba1 mutation increases formation and spread of alpha-synuclein deposits in mice injected with mouse alpha-synuclein pre-formed fibrils","volume":"15","author":"Migdalska-Richards","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.conb.2021.09.004_sref34","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/hmg\/ddz030","article-title":"GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson's disease","volume":"28","author":"Ikuno","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.09.004_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0233-5","article-title":"alpha-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism","volume":"13","author":"Yun","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.conb.2021.09.004_bib36","first-page":"2645","article-title":"Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease","volume":"25","author":"Rockenstein","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.09.004_bib37","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/brain\/awt367","article-title":"Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease","volume":"137","author":"Murphy","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.09.004_bib38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41586-020-1968-7","article-title":"ATP13A2 deficiency disrupts lysosomal polyamine export","volume":"578","author":"van Veen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.conb.2021.09.004_bib39","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/mds.23774","article-title":"Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond","volume":"26","author":"Shachar","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.conb.2021.09.004_bib40","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.conb.2021.09.004_bib41","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/hmg\/ddt057","article-title":"Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited alpha-synuclein accumulation and age-dependent sensorimotor deficits","volume":"22","author":"Schultheis","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.09.004_bib42","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1523\/JNEUROSCI.0632-14.2015","article-title":"alpha-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2","volume":"35","author":"Kett","year":"2015","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.conb.2021.09.004_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nbd.2014.10.007","article-title":"alpha-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)","volume":"73","author":"Daniel","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2021.09.004_bib44","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/hmg\/ddu099","article-title":"Parkinson's disease-linked human PARK9\/ATP13A2 maintains zinc homeostasis and promotes alpha-Synuclein externalization via exosomes","volume":"23","author":"Kong","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.09.004_bib45","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1523\/JNEUROSCI.5575-11.2012","article-title":"Deficiency of ATP13A2 leads to lysosomal dysfunction, alpha-synuclein accumulation, and neurotoxicity","volume":"32","author":"Usenovic","year":"2012","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.conb.2021.09.004_bib46","first-page":"22","article-title":"ATP13A2 regulates cellular alpha-synuclein multimerization, membrane association, and externalization","author":"Si","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.conb.2021.09.004_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fchem.2018.00010","article-title":"Polyamines: bio-molecules with diverse functions in plant and human health and disease","volume":"6","author":"Handa","year":"2018","journal-title":"Front Chem"},{"key":"10.1016\/j.conb.2021.09.004_bib48","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.25516","article-title":"A\u00a0metabolic profile of polyamines in Parkinson disease: a promising biomarker","volume":"86","author":"Saiki","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2021.09.004_bib49","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00401-020-02219-6","article-title":"Segregation of ATP10B variants in families with autosomal recessive parkinsonism","volume":"140","author":"Tesson","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.conb.2021.09.004_sref50","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00401-020-02145-7","article-title":"Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export","volume":"139","author":"Martin","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.conb.2021.09.004_sref51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41586-021-03185-z","article-title":"A\u00a0growth-factor-activated lysosomal K(+) channel regulates Parkinson's pathology","volume":"591","author":"Wie","year":"2021","journal-title":"Nature"}],"container-title":["Current Opinion in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438821001057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438821001057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:01:35Z","timestamp":1760706095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959438821001057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":51,"alternative-id":["S0959438821001057"],"URL":"https:\/\/doi.org\/10.1016\/j.conb.2021.09.004","relation":{},"ISSN":["0959-4388"],"issn-type":[{"value":"0959-4388","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rodent models based on endolysosomal genes involved in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conb.2021.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}